Product Details

Veramox-CV Oral Suspension combines Amoxicillin with Potassium Clavulanate for the effective treatment of bacterial infections, particularly those caused by beta-lactamase-producing organisms. Specifically, each 5ml of reconstituted suspension delivers Amoxicillin Trihydrate equivalent to 200mg Amoxicillin together with Potassium Clavulanate equivalent to 28.5mg Clavulanic Acid. As a result, it offers broad-spectrum antibacterial coverage extended by resistance protection in a convenient paediatric-friendly liquid formulation.

The suspension combines:

• Amoxicillin Trihydrate IP (equivalent to Amoxicillin 200mg per 5ml) – A broad-spectrum, beta-lactam antibiotic of the aminopenicillin class that inhibits bacterial cell wall synthesis. Consequently, it disrupts the structural integrity of susceptible bacteria, leading to cell lysis and death.
• Potassium Clavulanate IP (equivalent to Clavulanic Acid 28.5mg per 5ml) – A beta-lactamase inhibitor that protects Amoxicillin from degradation by bacterial enzymes. As a result, it extends Amoxicillin’s effectiveness against resistant strains that would otherwise inactivate it.

Physicians prescribe Veramox-CV for the treatment of bacterial infections resistant to Amoxicillin alone, including respiratory tract infections, ear, nose, and throat infections, urinary tract infections, and skin and soft tissue infections in children. In addition, its oral suspension format supports accurate paediatric dosing and easier administration than tablets or capsules. Because of this profile, Veramox-CV suits paediatric practices, general practice, and hospital settings treating resistant bacterial infections in young patients.

Key Features:

• Overall, this combination formulation guarantees pharmaceutical-grade purity across both actives
• Additionally, the beta-lactamase inhibitor extends antibacterial coverage against resistant strains
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 228.5mg total
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, light-protected bottle packaging preserves suspension stability
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies